Antipsychotics and brain insulin in women
Treatments studied
Part of Hormones & metabolism clinical trials.
This study looks at how a common antipsychotic medication (olanzapine) affects how the brain uses insulin in young women. It aims to understand weight gain and metabolic changes linked to these drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 35 years old.
- You have a body mass index (BMI) between 18.5 and 24.9 (healthy weight range).
- You have regular menstrual cycles (every 21 to 35 days) for the past 6 months.
- You do not have a history of psychiatric illness or diabetes.
- You are not using hormonal birth control (like the pill, patch, or hormonal IUD) and have had at least two periods since stopping it.
- You are not pregnant, breastfeeding, or within one year of giving birth.
- You do not have any metal implants, pacemaker, or other MRI safety issues.
- You are not taking certain medications like weight loss drugs or dopamine agonists.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
This study tests whether a single dose of a common antipsychotic medication affects how the brain responds to insulin, which could help explain weight gain and metabolic side effects. Healthy young adults will receive either the antipsychotic or a placebo, then have their brain activity measured with an MRI.
This study tests whether unusual insulin action in the brain is linked to thinking problems and body/metabolic issues in schizophrenia. It may help researchers understand the cause and identify targets for future treatments.
This trial tests whether metformin can help adults with intellectual disability who gained weight from long-term antipsychotic medicines. If you qualify, you may be assigned metformin to improve weight and related health measures.
This study tests whether adding aripiprazole to your current antipsychotic medication can help with weight gain and metabolic side effects. It is for women aged 18 to 65 who have schizophrenia or schizoaffective disorder and are currently taking olanzapine, clozapine, or risperidone.
This trial tests a new combination tablet (olanzapine-samidorphan) for adults with schizophrenia. It aims to see if it helps control symptoms while potentially reducing weight gain, which can be a side effect of some schizophrenia medicines.
Hear when a new Insulin Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.